RUBICON ORGANICS INC (ROMJ.CA) Fundamental Analysis & Valuation

TSX-V:ROMJ • CA78112W1005

Current stock price

0.485 CAD
-0.01 (-2.02%)
Last:

This ROMJ.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ROMJ.CA Profitability Analysis

1.1 Basic Checks

  • ROMJ had positive earnings in the past year.
  • In the past year ROMJ had a positive cash flow from operations.
  • In the past 5 years ROMJ always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ROMJ reported negative operating cash flow in multiple years.
ROMJ.CA Yearly Net Income VS EBIT VS OCF VS FCFROMJ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.93%, ROMJ belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • ROMJ has a better Return On Equity (7.01%) than 81.82% of its industry peers.
  • With an excellent Return On Invested Capital value of 23.98%, ROMJ belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ROMJ is significantly above the industry average of 9.22%.
  • The last Return On Invested Capital (23.98%) for ROMJ is above the 3 year average (19.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.93%
ROE 7.01%
ROIC 23.98%
ROA(3y)-4.91%
ROA(5y)-14.11%
ROE(3y)-7.24%
ROE(5y)-22.2%
ROIC(3y)19.33%
ROIC(5y)N/A
ROMJ.CA Yearly ROA, ROE, ROICROMJ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.65%, ROMJ is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
  • ROMJ has a Operating Margin of 31.50%. This is amongst the best in the industry. ROMJ outperforms 100.00% of its industry peers.
  • ROMJ has a better Gross Margin (64.91%) than 84.85% of its industry peers.
  • In the last couple of years the Gross Margin of ROMJ has grown nicely.
Industry RankSector Rank
OM 31.5%
PM (TTM) 5.65%
GM 64.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.88%
GM growth 5YN/A
ROMJ.CA Yearly Profit, Operating, Gross MarginsROMJ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ROMJ.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ROMJ is creating value.
  • ROMJ has more shares outstanding than it did 1 year ago.
  • ROMJ has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ROMJ has been reduced compared to a year ago.
ROMJ.CA Yearly Shares OutstandingROMJ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ROMJ.CA Yearly Total Debt VS Total AssetsROMJ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that ROMJ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 1.83, ROMJ belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
  • ROMJ has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • ROMJ has a better Debt to Equity ratio (0.17) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACC2.62
WACC9.14%
ROMJ.CA Yearly LT Debt VS Equity VS FCFROMJ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • ROMJ has a Current Ratio of 3.10. This indicates that ROMJ is financially healthy and has no problem in meeting its short term obligations.
  • ROMJ's Current ratio of 3.10 is fine compared to the rest of the industry. ROMJ outperforms 75.76% of its industry peers.
  • A Quick Ratio of 1.33 indicates that ROMJ should not have too much problems paying its short term obligations.
  • The Quick ratio of ROMJ (1.33) is better than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 1.33
ROMJ.CA Yearly Current Assets VS Current LiabilitesROMJ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ROMJ.CA Growth Analysis

3.1 Past

  • ROMJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 228.33%, which is quite impressive.
  • ROMJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.55%.
  • ROMJ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.14% yearly.
EPS 1Y (TTM)228.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1475.86%
Revenue 1Y (TTM)28.55%
Revenue growth 3Y29.14%
Revenue growth 5YN/A
Sales Q2Q%15.77%

3.2 Future

  • ROMJ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.44% yearly.
  • Based on estimates for the next years, ROMJ will show a very strong growth in Revenue. The Revenue will grow by 21.41% on average per year.
EPS Next Y216.68%
EPS Next 2Y93.65%
EPS Next 3Y80.44%
EPS Next 5YN/A
Revenue Next Year21.78%
Revenue Next 2Y22.22%
Revenue Next 3Y21.41%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ROMJ.CA Yearly Revenue VS EstimatesROMJ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ROMJ.CA Yearly EPS VS EstimatesROMJ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

8

4. ROMJ.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.70, the valuation of ROMJ can be described as reasonable.
  • Based on the Price/Earnings ratio, ROMJ is valued cheaper than 84.85% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ROMJ to the average of the S&P500 Index (25.23), we can say ROMJ is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 6.86, the valuation of ROMJ can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ROMJ is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 22.42. ROMJ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.7
Fwd PE 6.86
ROMJ.CA Price Earnings VS Forward Price EarningsROMJ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ROMJ is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.67
ROMJ.CA Per share dataROMJ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ROMJ has a very decent profitability rating, which may justify a higher PE ratio.
  • ROMJ's earnings are expected to grow with 80.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y93.65%
EPS Next 3Y80.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ROMJ.CA Dividend Analysis

5.1 Amount

  • ROMJ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ROMJ.CA Fundamentals: All Metrics, Ratios and Statistics

RUBICON ORGANICS INC

TSX-V:ROMJ (3/20/2026, 7:00:00 PM)

0.485

-0.01 (-2.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-11
Earnings (Next)03-30
Inst Owners3.35%
Inst Owner ChangeN/A
Ins Owners43.21%
Ins Owner ChangeN/A
Market Cap32.78M
Revenue(TTM)57.19M
Net Income(TTM)3.23M
Analysts82.86
Price Target1.17 (141.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)345.55%
Min EPS beat(2)-0.99%
Max EPS beat(2)692.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.42%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)15.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.7
Fwd PE 6.86
P/S 0.57
P/FCF N/A
P/OCF 12.96
P/B 0.71
P/tB 0.75
EV/EBITDA 1.67
EPS(TTM)0.05
EY10.31%
EPS(NY)0.07
Fwd EY14.58%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY7.72%
SpS0.85
BVpS0.68
TBVpS0.65
PEG (NY)0.04
PEG (5Y)N/A
Graham Number0.88
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 7.01%
ROCE 33.31%
ROIC 23.98%
ROICexc 27.36%
ROICexgc 28.81%
OM 31.5%
PM (TTM) 5.65%
GM 64.91%
FCFM N/A
ROA(3y)-4.91%
ROA(5y)-14.11%
ROE(3y)-7.24%
ROE(5y)-22.2%
ROIC(3y)19.33%
ROIC(5y)N/A
ROICexc(3y)24.75%
ROICexc(5y)N/A
ROICexgc(3y)26.66%
ROICexgc(5y)N/A
ROCE(3y)26.85%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.88%
GM growth 5YN/A
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 0.37
Cap/Depr 212.76%
Cap/Sales 12.07%
Interest Coverage 20.97
Cash Conversion 11.9%
Profit Quality N/A
Current Ratio 3.1
Quick Ratio 1.33
Altman-Z 1.83
F-Score6
WACC9.14%
ROIC/WACC2.62
Cap/Depr(3y)93.56%
Cap/Depr(5y)171.69%
Cap/Sales(3y)7.51%
Cap/Sales(5y)22.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)228.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1475.86%
EPS Next Y216.68%
EPS Next 2Y93.65%
EPS Next 3Y80.44%
EPS Next 5YN/A
Revenue 1Y (TTM)28.55%
Revenue growth 3Y29.14%
Revenue growth 5YN/A
Sales Q2Q%15.77%
Revenue Next Year21.78%
Revenue Next 2Y22.22%
Revenue Next 3Y21.41%
Revenue Next 5YN/A
EBIT growth 1Y65.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-64.02%
EBIT Next 3Y-0.22%
EBIT Next 5YN/A
FCF growth 1Y-228.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.76%
OCF growth 3YN/A
OCF growth 5YN/A

RUBICON ORGANICS INC / ROMJ.CA Fundamental Analysis FAQ

What is the fundamental rating for ROMJ stock?

ChartMill assigns a fundamental rating of 6 / 10 to ROMJ.CA.


Can you provide the valuation status for RUBICON ORGANICS INC?

ChartMill assigns a valuation rating of 8 / 10 to RUBICON ORGANICS INC (ROMJ.CA). This can be considered as Undervalued.


Can you provide the profitability details for RUBICON ORGANICS INC?

RUBICON ORGANICS INC (ROMJ.CA) has a profitability rating of 7 / 10.


What is the financial health of RUBICON ORGANICS INC (ROMJ.CA) stock?

The financial health rating of RUBICON ORGANICS INC (ROMJ.CA) is 5 / 10.


What is the earnings growth outlook for RUBICON ORGANICS INC?

The Earnings per Share (EPS) of RUBICON ORGANICS INC (ROMJ.CA) is expected to grow by 216.68% in the next year.